These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32646346)

  • 1. New ophthalmic drug delivery systems.
    Castro-Balado A; Mondelo-García C; Zarra-Ferro I; Fernández-Ferreiro A
    Farm Hosp; 2020 Jul; 44(4):149-157. PubMed ID: 32646346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical drug delivery devices: A review.
    Bertens CJF; Gijs M; van den Biggelaar FJHM; Nuijts RMMA
    Exp Eye Res; 2018 Mar; 168():149-160. PubMed ID: 29352994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular preparations: the formulation approach.
    Kaur IP; Kanwar M
    Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqueous eye drops containing drug/cyclodextrin nanoparticles deliver therapeutic drug concentrations to both anterior and posterior segment.
    Loftsson T; Stefánsson E
    Acta Ophthalmol; 2022 Feb; 100(1):7-25. PubMed ID: 33876553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent perspectives for corticosteroids based ophthalmic therapeutics.
    Suresh PK; Sah AK
    Recent Pat Drug Deliv Formul; 2014; 8(3):206-23. PubMed ID: 25020063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye.
    Loftsson T; Stefánsson E
    Int J Pharm; 2017 Oct; 531(2):413-423. PubMed ID: 28391041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent patents on ocular drug delivery systems.
    Conway BR
    Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
    Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
    J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery to the posterior segment of the eye.
    Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
    Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colloidal carriers for ophthalmic drug delivery.
    Mainardes RM; Urban MC; Cinto PO; Khalil NM; Chaud MV; Evangelista RC; Gremiao MP
    Curr Drug Targets; 2005 May; 6(3):363-71. PubMed ID: 15857294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on revolutionizing ophthalmic therapy: Unveiling the potential of chitosan, hyaluronic acid, cellulose, cyclodextrin, and poloxamer in eye disease treatments.
    Wang TJ; Rethi L; Ku MY; Nguyen HT; Chuang AE
    Int J Biol Macromol; 2024 Jul; 273(Pt 2):132700. PubMed ID: 38879998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on recent drug delivery systems for posterior segment of eye.
    Nayak K; Misra M
    Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent updates on ocular disease management with ophthalmic ointments.
    Bisen AC; Dubey A; Agrawal S; Biswas A; Rawat KS; Srivastava S; Bhatta RS
    Ther Deliv; 2024; 15(6):463-480. PubMed ID: 38888757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-based ocular drug delivery systems: an insight into the preclinical/clinical studies and their potential in the treatment of posterior ocular diseases.
    Su Y; Fan X; Pang Y
    Biomater Sci; 2023 Jun; 11(13):4490-4507. PubMed ID: 37222479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
    Del Amo EM; Urtti A
    Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periocular routes for retinal drug delivery.
    Raghava S; Hammond M; Kompella UB
    Expert Opin Drug Deliv; 2004 Nov; 1(1):99-114. PubMed ID: 16296723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices for the treatment of eye diseases.
    Yasukawa T; Ogura Y
    Handb Exp Pharmacol; 2010; (197):469-89. PubMed ID: 20217540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous formulations and ointments.
    MacKeen DL
    Int Ophthalmol Clin; 1980; 20(3):79-92. PubMed ID: 6998903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ophthalmic drug dosage forms: characterisation and research methods.
    Baranowski P; Karolewicz B; Gajda M; Pluta J
    ScientificWorldJournal; 2014; 2014():861904. PubMed ID: 24772038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.